Your browser doesn't support javascript.
loading
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Kremsner, Peter G; Mann, Philipp; Kroidl, Arne; Leroux-Roels, Isabel; Schindler, Christoph; Gabor, Julian J; Schunk, Mirjam; Leroux-Roels, Geert; Bosch, Jacobus J; Fendel, Rolf; Kreidenweiss, Andrea; Velavan, Thirumalaisamy P; Fotin-Mleczek, Mariola; Mueller, Stefan O; Quintini, Gianluca; Schönborn-Kellenberger, Oliver; Vahrenhorst, Dominik; Verstraeten, Thomas; Alves de Mesquita, Margarida; Walz, Lisa; Wolz, Olaf-Oliver; Oostvogels, Lidia.
Affiliation
  • Kremsner PG; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Mann P; German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
  • Kroidl A; Centre de Recherches Medicales de Lambarene, Lambarene, Gabon.
  • Leroux-Roels I; CureVac AG, Schumannstraße 27, 60325, Frankfurt, Germany. Philipp.Mann@curevac.com.
  • Schindler C; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Gabor JJ; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.
  • Schunk M; Ghent University Hospital, Ghent, Belgium.
  • Leroux-Roels G; Hannover Medical School (MHH), Hannover, Germany.
  • Bosch JJ; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Fendel R; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Kreidenweiss A; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.
  • Velavan TP; Ghent University Hospital, Ghent, Belgium.
  • Fotin-Mleczek M; Hannover Medical School (MHH), Hannover, Germany.
  • Mueller SO; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Quintini G; German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
  • Schönborn-Kellenberger O; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Vahrenhorst D; German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
  • Verstraeten T; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Alves de Mesquita M; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Viet Nam.
  • Walz L; CureVac AG, Tübingen, Germany.
  • Wolz OO; CureVac AG, Schumannstraße 27, 60325, Frankfurt, Germany.
  • Oostvogels L; CureVac AG, Tübingen, Germany.
Wien Klin Wochenschr ; 133(17-18): 931-941, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34378087
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / Nanoparticles / COVID-19 Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Wien Klin Wochenschr Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / Nanoparticles / COVID-19 Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Wien Klin Wochenschr Year: 2021 Type: Article Affiliation country: Germany